CARRINGTON LABORATORIES Inc.(Brief Article)

Chemical Market Reporter, June, 2000

CARRINGTON LABORATORIES Inc. received Food and Drug Administration approval to market a new, sterile and preservative-free hydrogel containing Acemannan Hydrogel. Carrington expects to launch the new product by September and will market it under the brand name Ultrex for the management of pressure and stasis ulcers, post-surgical incisions, first- and second-degree burns and skin conditions associated with peristomal care.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here